NCT04893564
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- CHU Amiens Amiens, France
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,963 public trials
2,020 recruiting studies
Immunoproliferative Disorders trial results
NCT04902807
- Conditions
- APECED, Arthritis, Arthritis, Juvenile, +65 more
- Locations
-
- hôpital Necker Enfants Malades Paris, France
NCT06383338
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
- Locations
-
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
NCT05884333
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +26 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT07159620
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Copenhagen Neuromuscular Center, Rigshospitalet Blegdamsvej. København Ø, Denmark
NCT06274788
- Conditions
- Essential Fatty Acid Deficiency, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Memorial Health Service Fountain Valley, California, United States
- University of California Los Angeles Los Angeles, California, United States
- The University of Chicago Chicago, Illinois, United States
- Children's Hospital Corporation d/b/a Boston Children's Hospital Boston, Massachusetts, United States
NCT05372354
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UAB Comprehensive Cancer Center Birmingham, Alabama, United States
- Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- John Theurer Cancer Center at Hackensack UMC Hackensack, New Jersey, United States
Recruiting
Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma
NCT06160843
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- National Cancer Centre, Singapore Singapore
NCT03081910
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States